Samlyn Capital, LLC Logic Bio Therapeutics, Inc. Transaction History

Samlyn Capital, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $921,964 - $3.76 Million	-1,511,417 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.2 - $4.53 $82,079 - $169,009	37,309 Added 2.53%	1,511,417 $3.49 Million
Q3 2021 Nov 15, 2021	BUY	$3.85 - $5.09 $206,575 - $273,109	53,656 Added 3.78%	1,474,108 $6.75 Million
Q2 2021 Aug 16, 2021	BUY	$4.03 - $7.57 $83,050 - $156,002	20,608 Added 1.47%	1,420,452 $6.31 Million
Q1 2021 May 17, 2021	SELL	$6.8 - $9.16 $119,693 - $161,234	-17,602 Reduced 1.24%	1,399,844 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$5.29 - $9.1 $3.4 Million - $5.86 Million	643,551 Added 83.16%	1,417,446 $10.8 Million
Q3 2020 Nov 16, 2020	SELL	$5.41 - $9.45 $70,979 - $123,983	-13,120 Reduced 1.67%	773,895 $7.03 Million
Q2 2020 Aug 14, 2020	SELL	$4.25 - $8.46 $49,091 - $97,721	-11,551 Reduced 1.45%	787,015 $6.66 Million
Q1 2020 May 15, 2020	BUY	$4.06 - $11.0 $237,591 - $643,720	58,520 Added 7.91%	798,566 $3.95 Million
Q4 2019 Feb 14, 2020	BUY	$7.01 - $11.01 $701,483 - $1.1 Million	100,069 Added 15.64%	740,046 $5.33 Million
Q3 2019 Nov 14, 2019	BUY	$6.97 - $13.46 $10,301 - $19,893	1,478 Added 0.23%	639,977 $6.92 Million
Q2 2019 Aug 14, 2019	BUY	$9.77 - $17.08 $41,190 - $72,009	4,216 Added 0.66%	638,499 $8.3 Million
Q1 2019 May 15, 2019	BUY	$7.93 - $10.41 $672,019 - $882,185	84,744 Added 15.42%	634,283 $6.27 Million
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $4.33 Million - $9.88 Million	549,539 New	549,539 $5.72 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.